Infection and anti-tumor necrosis factor-alpha therapy

被引：0
|
作者：
Zandman-Goddard, G [1 ]
机构：
[1] Chaim Sheba Med Ctr, Dept Med B, IL-52621 Tel Hashomer, Israel
[2] Chaim Sheba Med Ctr, Ctr Autoimmune Dis, IL-52621 Tel Hashomer, Israel
来源：
ISRAEL MEDICAL ASSOCIATION JOURNAL | 2003年 / 5卷 / 11期
关键词：
infection; tuberculosis; Listeria; histoplasmosis; infliximab; etanercept;
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：814 / 816
页数：3
相关论文
共 50 条
  • [31] Listeria monocytogenes sepsis in patients treated with anti-tumor necrosis factor-alpha
    Tweezer-Zaks, N
    Shiloach, E
    Spivak, A
    Rapoport, M
    Novis, B
    Langevitz, P
    ISRAEL MEDICAL ASSOCIATION JOURNAL, 2003, 5 (11): : 829 - 830
  • [32] Emerging data on the use of anti-tumor necrosis factor-alpha medications in pregnancy
    Chambers, Christina D.
    Johnson, Diana L.
    BIRTH DEFECTS RESEARCH PART A-CLINICAL AND MOLECULAR TERATOLOGY, 2012, 94 (08) : 607 - 611
  • [33] Pregnancy and exposure to infliximab (anti-tumor necrosis factor-alpha monoclonal antibody)
    Burt, MJ
    Frizelle, FA
    Barbezat, GO
    JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 2003, 18 (04) : 465 - U3
  • [34] Development of miliary tuberculosis related to anti-tumor necrosis factor-alpha inhibitor therapy for pustular psoriasis
    Koga, Monji
    Terawaki, Shiho
    Tatsukawa, Ryoko
    Fujita, Masaki
    Imafuku, Shinichi
    Nakayama, Juichiro
    JOURNAL OF DERMATOLOGY, 2013, 40 (06): : 476 - 477
  • [35] Multiple sclerosis following anti-tumor necrosis factor-alpha therapy for psoriasis: first case in Italy?
    Napolitano, Maddalena
    Balato, Nicola
    Ayala, Fabio
    Cirillo, Teresa
    Balato, Anna
    GIORNALE ITALIANO DI DERMATOLOGIA E VENEREOLOGIA, 2018, 153 (04): : 567 - 572
  • [36] Vitamin D status and response to anti-tumor necrosis factor-alpha therapy in inflammatory bowel disease
    Bak, N. F.
    Hald, S.
    Rasch, M. B.
    Dige, A.
    Agnholt, J. S.
    Dahlerup, J. F.
    JOURNAL OF CROHNS & COLITIS, 2015, 9 : S318 - S318
  • [37] Anti-tumor necrosis factor-alpha therapy with the chimeric monoclonal antibody infliximab in severe undifferentiated spondyloarthropathy
    Schnarr, S
    Huelsemann, JL
    Merkesdal, S
    Brandt, J
    Braun, J
    Prudlo-Winkler, S
    Zeidler, H
    ANNALS OF THE RHEUMATIC DISEASES, 2004, 63 : 422 - 422
  • [38] Anti-Tumor Necrosis Factor-alpha Therapy in the Management of Psoriasis and B-Chronic Lymphocytic Leukemia
    Balato, Anna
    Lembo, Serena
    Cirillo, Teresa
    Megna, Matteo
    Raimondo, Annunziata
    Di Costanzo, Luisa
    CASE REPORTS IN DERMATOLOGY, 2011, 3 (01): : 60 - 63
  • [39] Systematic Review of Anti-Tumor Necrosis Factor-alpha Therapy for Treatment of Immune-mediated Uveitis
    Cordero-Coma, Miguel
    Yilmaz, Taygan
    Onal, Sumru
    OCULAR IMMUNOLOGY AND INFLAMMATION, 2013, 21 (01) : 12 - 20
  • [40] Eosinophilia - A rare possible adverse reaction during anti-tumor necrosis factor-alpha therapy for psoriasis
    Chiriac, Anca
    Brzezinski, Piotr
    Stolnicu, Simona
    Podoleanu, Cristian
    Moldovan, Cosmin
    Molnar, Calin
    Taranu, Tatiana
    JOURNAL OF DERMATOLOGICAL TREATMENT, 2016, 27 (02) : 110 - 113
12345